Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

Exclusion criteria

• ✕. Subjects who are 12-18 months of age with INSS Stage 4 and all stage 3 subjects with favorable biologic features (ie, nonamplified MYCN, favorable pathology, and DNA index \> 1) are not eligible.
• ✕. Lactating females are not eligible unless they have agreed not to breastfeed their infants.
• ✕. Subjects receiving any investigational drug concurrently.
• ✕. Subjects with any other medical condition, including but not limited to malabsorption syndromes, mental illness or substance abuse, deemed by the Investigator to be likely to interfere with the interpretation of the results or which would interfere with a subject's ability to sign or the legal guardian's ability to sign the informed consent, and subject's ability to cooperate and participate in the study